Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
DOX Stock Forecast 2026-2027
$52.63
Current Price
$5.47B
Market Cap
Buy 3
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to DOX Price Targets
+99.5%
To High Target of $105.00
+41.6%
To Median Target of $74.50
+34.6%
To Low Target of $70.84
DOX Price Momentum
+1.4%
1 Week Change
+2.3%
1 Month Change
-41.1%
1 Year Change
-34.6%
Year-to-Date Change
-41.7%
From 52W High of $90.29
+5.7%
From 52W Low of $49.80
📊 TOP ANALYST CALLS
Did DOX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Amdocs is one of their latest high-conviction picks.
Latest DOX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, DOX has a neutral consensus with a median price target of $74.50 (ranging from $70.84 to $105.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $52.63, the median forecast implies a 41.6% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DOX Analyst Ratings
3
Buy
3
Hold
0
Sell
DOX Price Target Range
Low
$70.84
Average
$74.50
High
$105.00
Current: $52.63
Latest DOX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DOX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 29, 2026 | Keybanc | Devin Au | Sector Weight | Initiates | $N/A |
| May 14, 2026 | Stifel | Buy | Maintains | $N/A | |
| Feb 5, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Feb 4, 2026 | Stifel | Buy | Maintains | $N/A | |
| Nov 13, 2025 | Wolfe Research | Peer Perform | Downgrade | $N/A | |
| Nov 12, 2025 | Stifel | Buy | Maintains | $N/A | |
| Nov 12, 2025 | B of A Securities | Buy | Maintains | $N/A | |
| Jul 8, 2025 | Wolfe Research | Outperform | Initiates | $N/A | |
| Nov 14, 2024 | Barclays | Overweight | Maintains | $N/A | |
| Nov 13, 2024 | Oppenheimer | Outperform | Maintains | $N/A | |
| Oct 2, 2024 | Stifel | Buy | Initiates | $N/A | |
| May 9, 2024 | Citigroup | Buy | Maintains | $N/A | |
| May 9, 2024 | Baird | Neutral | Maintains | $N/A | |
| Feb 8, 2024 | Barclays | Overweight | Maintains | $N/A | |
| Jan 17, 2024 | Citigroup | Buy | Maintains | $N/A | |
| Dec 1, 2023 | Jefferies | Buy | Initiates | $N/A | |
| Aug 3, 2023 | Oppenheimer | Outperform | Maintains | $N/A | |
| May 16, 2023 | Barclays | Overweight | Upgrade | $N/A | |
| May 11, 2023 | Oppenheimer | Outperform | Reiterates | $N/A | |
| Feb 2, 2023 | Baird | Neutral | Maintains | $N/A |
Amdocs Limited (DOX) Competitors
The following stocks are similar to Amdocs based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Amdocs Limited (DOX) Financial Data
Amdocs Limited has a market capitalization of $5.47B with a P/E ratio of 10.2x. The company generates $4.62B in trailing twelve-month revenue with a 11.8% profit margin.
Revenue growth is +3.9% quarter-over-quarter, while maintaining an operating margin of +16.5% and return on equity of +15.9%.
Valuation Metrics
Market Cap
$5.47B
Enterprise Value
$6.50B
P/E Ratio
10.2x
PEG Ratio
-0.9x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
+3.9%
Gross Margin
+38.8%
Operating Margin
+16.5%
Net Margin
+11.8%
EPS Growth
-15.6%
Financial Health
Cash/Price Ratio
+3.8%
Current Ratio
1.0x
Debt/Equity
31.2x
ROE
+15.9%
ROA
+8.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Amdocs Limited (DOX) Business Model
About Amdocs Limited
What They Do
Provides software and services for communications companies.
Business Model
The company generates revenue by offering software solutions and services that facilitate digital network transformation for communications and media companies. Amdocs’ business model includes partnerships with major telecom operators, allowing them to enhance operations and customer experiences through innovative technologies like Generative AI, 5G capabilities, and cloud services.
Additional Information
Amdocs is headquartered in St. Louis, Missouri, and has significant development operations in India and Israel. It focuses on B2B processes from sales to monetization and also provides solutions for financial services, positioning itself to meet the demands of both developed and emerging markets.
Company Information
Sector
Technology
Industry
Software - Infrastructure
Employees
26,969
CEO
Mr. Shimie Hortig
Country
United States
IPO Year
1998
Website
www.amdocs.comAmdocs Limited (DOX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
DOX vs. JKHY: Which Stock Is the Better Value Option?
DOX vs. JKHY: Which Stock Is the Better Value Option?
Jul 16, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Zacks utilizes its Rank system, focusing on earnings estimates and revisions, while also monitoring value, growth, and momentum trends to identify strong stock picks.
Why It Matters
The Zacks Rank system highlights stocks with favorable earnings revisions, signaling potential growth. This focus on trends aids investors in identifying strong investment opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Recent data suggests that large-cap stocks may not be the best investment option currently.
Why It Matters
Shifts in data suggest large-cap stocks may underperform, prompting investors to reconsider their portfolios and potentially seek opportunities in mid or small-cap stocks.
Source: Market Watch
Market Sentiment:
Positive
Quick Summary
Palm Valley Capital Fund added positions in Clorox, Molson Coors, and Vontier in Q2, while selling Heartland Express. Amdocs, LKQ, and Chord Energy negatively impacted returns.
Why It Matters
Palm Valley's acquisition of Clorox, Molson Coors, and Vontier indicates a shift in strategy, potentially signaling growth sectors. The sale of Heartland Express and underperforming stocks may impact overall fund performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Amdocs Expands Store Genie to PLDT Home, Bringing Agentic AI to Broadband Customer Service Operations
24 days ago
Quick Summary
Amdocs has launched Store Genie for PLDT Home, enhancing retail operations and reducing customer resolution time by up to 98%. Amdocs' stock (NASDAQ: DOX) may be of interest to investors.
Why It Matters
Amdocs' deployment of Store Genie at PLDT Home enhances operational efficiency and customer service, potentially boosting PLDT's performance and positively impacting Amdocs' stock value.
Source: Accesswire
Market Sentiment:
Neutral
Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
24 days ago
Quick Summary
Amdocs, Supermicro, and 1Finity have deployed NVIDIA AI infrastructure on Red Hat Openshift to enhance RAN workloads, targeting improved network efficiency for communications service providers.
Why It Matters
The deployment of NVIDIA AI infrastructure by Amdocs, Supermicro, and 1Finity signals advancements in AI-driven network efficiency, potentially boosting the competitiveness and profitability of involved companies.
Source: Accesswire
Market Sentiment:
Neutral
Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
23 days ago
Quick Summary
Amdocs (NASDAQ: DOX) has been chosen by telecom operator Three Scandinavia to support its digital transformation in Sweden and Denmark, enhancing customer engagement and operational efficiency.
Why It Matters
Amdocs' partnership with Three Scandinavia signals growth potential in the Nordic telecom market, enhancing customer engagement with AI solutions, likely boosting future revenues and market position.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About DOX Stock
What is Amdocs Limited's (DOX) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Amdocs Limited (DOX) has a median price target of $74.50. The highest price target is $105.00 and the lowest is $70.84.
Is DOX stock a good investment in 2027?
According to current analyst ratings, DOX has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $52.63. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DOX stock?
Wall Street analysts predict DOX stock could reach $74.50 in the next 12 months. This represents a 41.6% increase from the current price of $52.63. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Amdocs Limited's business model?
The company generates revenue by offering software solutions and services that facilitate digital network transformation for communications and media companies. Amdocs’ business model includes partnerships with major telecom operators, allowing them to enhance operations and customer experiences through innovative technologies like Generative AI, 5G capabilities, and cloud services.
What is the highest forecasted price for DOX Amdocs Limited?
The highest price target for DOX is $105.00 from at , which represents a 99.5% increase from the current price of $52.63.
What is the lowest forecasted price for DOX Amdocs Limited?
The lowest price target for DOX is $70.84 from at , which represents a 34.6% increase from the current price of $52.63.
What is the overall DOX consensus from analysts for Amdocs Limited?
The overall analyst consensus for DOX is neutral. Out of 2 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $74.50.
How accurate are DOX stock price projections?
Stock price projections, including those for Amdocs Limited, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:21 AM UTC